Literature DB >> 17113466

Clinical and immunological diversity of limbic encephalitis: a model for paraneoplastic neurologic disorders.

Josep Dalmau1, Luis Bataller.   

Abstract

The most important contribution to the understanding and management of paraneoplastic neurologic disorders (PND) is the discovery that many of these diseases are immune mediated. It is believed that cytotoxic T-cell responses and antibodies that target neuronal proteins usually expressed by the underlying tumor cause the neurologic symptoms. The detection of these antibodies has provided diagnostic tests that allow recognition of the disorder as paraneoplastic and direct the search of the tumor to selected organs. This article summarizes the authors' findings of limbic encephalitis and postulates that a similar approach can be used for syndromes involving other areas of the nervous system.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17113466      PMCID: PMC1920176          DOI: 10.1016/j.hoc.2006.09.011

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  64 in total

1.  Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients.

Authors:  F Graus; F Keime-Guibert; R Reñe; B Benyahia; T Ribalta; C Ascaso; G Escaramis; J Y Delattre
Journal:  Brain       Date:  2001-06       Impact factor: 13.501

2.  "Limbic encephalitis" and its association with carcinoma.

Authors:  J A Corsellis; G J Goldberg; A R Norton
Journal:  Brain       Date:  1968-09       Impact factor: 13.501

3.  Focal paraneoplastic limbic encephalitis presenting as orgasmic epilepsy.

Authors:  C E Fadul; E W Stommel; K H Dragnev; C J Eskey; J O Dalmau
Journal:  J Neurooncol       Date:  2005-04       Impact factor: 4.130

4.  Anti-Hu-associated peripheral nerve and muscle microvasculitis.

Authors:  D S Younger; J Dalmau; G Inghirami; W H Sherman; A P Hays
Journal:  Neurology       Date:  1994-01       Impact factor: 9.910

5.  A serologic marker of paraneoplastic limbic and brain-stem encephalitis in patients with testicular cancer.

Authors:  R Voltz; S H Gultekin; M R Rosenfeld; E Gerstner; J Eichen; J B Posner; J Dalmau
Journal:  N Engl J Med       Date:  1999-06-10       Impact factor: 91.245

6.  Carcinoma associated paraneoplastic peripheral neuropathies in patients with and without anti-onconeural antibodies.

Authors:  J C Antoine; J F Mosnier; L Absi; P Convers; J Honnorat; D Michel
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-07       Impact factor: 10.154

7.  Detection of the anti-Hu antibody in the serum of patients with small cell lung cancer--a quantitative western blot analysis.

Authors:  J Dalmau; H M Furneaux; R J Gralla; M G Kris; J B Posner
Journal:  Ann Neurol       Date:  1990-05       Impact factor: 10.422

8.  Bilateral horizontal gaze palsy in presumed paraneoplastic brainstem encephalitis associated with a benign ovarian teratoma.

Authors:  Rajeev H Muni; Richard Wennberg; David J Mikulis; Agnes M F Wong
Journal:  J Neuroophthalmol       Date:  2004-06       Impact factor: 3.042

9.  Clinical analysis of anti-Ma2-associated encephalitis.

Authors:  Josep Dalmau; Francesc Graus; Alberto Villarejo; Jerome B Posner; Deborah Blumenthal; Brian Thiessen; Albert Saiz; Patricio Meneses; Myrna R Rosenfeld
Journal:  Brain       Date:  2004-06-23       Impact factor: 13.501

10.  Paraneoplastic limbic encephalitis masquerading as chronic behavioural disturbance in an adolescent girl.

Authors:  A C W Lee; Y Ou; W K Lee; Y C Wong
Journal:  Acta Paediatr       Date:  2003-04       Impact factor: 2.299

View more
  14 in total

Review 1.  Autoimmune-mediated encephalitis.

Authors:  Philippe Demaerel; Wim Van Dessel; Wim Van Paesschen; Rik Vandenberghe; Koen Van Laere; Jennifer Linn
Journal:  Neuroradiology       Date:  2011-01-27       Impact factor: 2.804

2.  Clinical reasoning: a 35-year-old woman with acute seizures and behavior change.

Authors:  Jared John Rejeski; John Christopher Morris; Francis O Walker; Nikhil Balakrishnan
Journal:  Neurology       Date:  2013-08-27       Impact factor: 9.910

Review 3.  Autoimmune Encephalitis: Pathophysiology and Imaging Review of an Overlooked Diagnosis.

Authors:  B P Kelley; S C Patel; H L Marin; J J Corrigan; P D Mitsias; B Griffith
Journal:  AJNR Am J Neuroradiol       Date:  2017-02-09       Impact factor: 3.825

4.  Metabolic topography of autoimmune non-paraneoplastic encephalitis.

Authors:  Madhavi Tripathi; Manjari Tripathi; Shambo Guha Roy; Girish Kumar Parida; Kavish Ihtisham; Deepa Dash; Nishikant Damle; Shamim Ahmed Shamim; Chandrasekhar Bal
Journal:  Neuroradiology       Date:  2017-12-18       Impact factor: 2.804

Review 5.  Recognizing Autoimmune-Mediated Encephalitis in the Differential Diagnosis of Limbic Disorders.

Authors:  A J da Rocha; R H Nunes; A C M Maia; L L F do Amaral
Journal:  AJNR Am J Neuroradiol       Date:  2015-09-17       Impact factor: 3.825

6.  Limbic encephalitis and related cortical syndromes.

Authors:  Ignacio Rubio-Agusti; Miguel Salavert; Luis Bataller
Journal:  Curr Treat Options Neurol       Date:  2013-04       Impact factor: 3.598

Review 7.  Clinical applications of a peptide-based vaccine for glioblastoma.

Authors:  Charles W Kanaly; Dale Ding; Amy B Heimberger; John H Sampson
Journal:  Neurosurg Clin N Am       Date:  2010-01       Impact factor: 2.509

8.  Limbic encephalitis as the presenting symptom of oesophageal adenocarcinoma: another cancer to search?

Authors:  Renata Barbosa Menezes; Adson Freitas de Lucena; Fernanda Martins Maia; Antônia Rosivalda Teixeira Marinho
Journal:  BMJ Case Rep       Date:  2013-04-16

9.  Adenylate kinase 5 autoimmunity in treatment refractory limbic encephalitis.

Authors:  Erdem Tüzün; Jeffrey E Rossi; Steve F Karner; Alejandro F Centurion; Josep Dalmau
Journal:  J Neuroimmunol       Date:  2007-04-25       Impact factor: 3.478

10.  Limbic Encephalitis in Patients with Epilepsy-is Quantitative MRI Diagnostic?

Authors:  Arndt-Hendrik Schievelkamp; Alina Jurcoane; Theodor Rüber; Leon Ernst; Andreas Müller; Burkhard Mädler; Hans Heinz Schild; Elke Hattingen
Journal:  Clin Neuroradiol       Date:  2018-07-16       Impact factor: 3.649

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.